Celldex Therapeutics, Inc. Operating Lease Right-of-Use Assets
Celldex Therapeutics, Inc. (CLDX) had Operating Lease Right-of-Use Assets of $5.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $5.04M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.01M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $2.44M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.72M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $5.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.01M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.44M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $2.72M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.12M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $3.51M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.90M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.17M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.45M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.17M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $2.58M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.86M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.26M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.63M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.00M 10-K · filed 2024-02-26 |
| 2022-09-30 | $3.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.94M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.56M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.97M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.02M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.72M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.09M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.45M 10-K · filed 2022-02-28 |
| 2020-09-30 | $3.80M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.13M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $3.74M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $3.47M 10-K · filed 2021-03-29 |
| 2019-09-30 | $3.43M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.97M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.45M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |